Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.25
Bid: 45.50
Ask: 47.00
Change: -0.50 (-1.07%)
Spread: 1.50 (3.297%)
Open: 45.75
High: 46.25
Low: 45.50
Prev. Close: 46.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Mon, 21st Sep 2020 16:08

Tuesday 22 September 
Judges Scientific PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Ergomed PLCHalf Year Results
ASA International Group PLCHalf Year Results
Alliance Pharma PLCHalf Year Results
Frenkel Topping Group PLCHalf Year Results
Parity Group PLCHalf Year Results
Bluefield Solar Income Fund LtdFull Year Results
Longboat Energy PLCHalf Year Results
NAHL GroupHalf Year Results
Tremor International LtdHalf Year Results
Litigation Capital Management LtdFull Year Results
Cambridge Cognition Holdings PLCHalf Year Results
Personal Group Holdings PLCHalf Year Results
Inspecs Group PLCHalf Year Results
Oriole Resources PLCHalf Year Results
Learning Technologies Group PLCHalf Year Results
Kingfisher PLCHalf Year Results
AG Barr PLCHalf Year Results
Town Centre SecuritiesFull Year Results
Mortgage Advice Bureau (Holdings) PLCHalf Year Results
ADES International Holding PLCHalf Year Results
Wednesday 23 September 
PZ Cussons PLCFull Year Results
Equals Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
ECSC Group PLCHalf Year Results
Xeros Technology Group PLCHalf Year Results
LoopUp Group PLCHalf Year Results
CloudCall Group PLCHalf Year Results
Ten Entertainment Group PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Staffline Group PLCHalf Year Results
Thursday 24 September 
CVS Group PLCFull Year Results
Smiths Group PLCFull Year Results
Go-Ahead Group PLCFull Year Results
SIG PLCHalf Year Results
GYG PLCHalf Year Results
Mitchells & Butlers PLCTrading Update
Safestay PLCHalf Year Results
Ebiquity PLCHalf Year Results
DFS Furniture PLCFull Year Results
Faron Pharmaceuticals LtdHalf Year Results
Pendragon PLCHalf Year Results
RTW Venture Fund LtdHalf Year Results
Cineworld Group PLCHalf Year Results
Funding Circle Hodlings PLCHalf Year Results
Baillie Gifford Shin Nippon PLCHalf Year Results
United Utilities Group PLCTrading Statement
Friday 25 September 
Camellia PLCHalf Year Results
Pennon Group PLCTrading Statement
Monday 28 September 
Brand Architekts Group PLCFull Year Results
7digital Group PLCHalf Year Results
Ceres Power Holdings PLCFull Year Results
Avacta Group PLCHalf Year Results
Instem PLCHalf Year Results
Chesnara PLCHalf Year Results
Reach PLCHalf Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Mar 2022 11:38

Avacta sells veterinary division to Vimian for up to GBP2.3 million

(Alliance News) - Avacta Group PLC on Wednesday said it sold its veterinary division Avacta Animal Health to veterinary company Vimian Group AB.

Read more
3 Feb 2022 12:31

Avacta moves to next dose in first-in-human chemotherapy trial

(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Thursday that the first-in-human phase 1 trial of 'AVA6000' pro-doxorubicin would advance to the next dose cohort, following a positive review of the safety data from the dosing of the first cohort.

Read more
3 Feb 2022 11:10

Avacta shares up 12% after chemotherapy drug advances to next stage

Avacta shares up 12% after chemotherapy drug advances to next stage

Read more
18 Jan 2022 14:36

Avacta Group selects second pro-drug candidate

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Tuesday that the next 'preCISION' drug candidate, 'AVA3996', had been selected for preclinical development, with a view to a first-in-human phase one clinical trial from the second half of 2023.

Read more
18 Jan 2022 13:52

Avacta selects potential tumour treatment for preclinical development

Avacta selects potential tumour treatment for preclinical development

Read more
18 Jan 2022 10:58

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers

Read more
10 Jan 2022 12:16

LONDON MARKET MIDDAY: Stocks slip as investors brace for Fed testimony

LONDON MARKET MIDDAY: Stocks slip as investors brace for Fed testimony

Read more
10 Jan 2022 12:08

Abingdon Health plunges after Avacta stops selling Covid-19 test

Abingdon Health plunges after Avacta stops selling Covid-19 test

Read more
10 Jan 2022 11:29

AIM WINNERS & LOSERS: Avacta sinks as halts sales of Covid-19 tests

AIM WINNERS & LOSERS: Avacta sinks as halts sales of Covid-19 tests

Read more
10 Jan 2022 11:05

Shares plummet as Avacta pauses sale of lateral flow tests

(Sharecast News) - Avacta Group has suspended sales of its antigen lateral flow tests, causing the AIM-listed firm's share price to plummet.

Read more
10 Jan 2022 09:20

Avacta shares drop as Covid tests show reduced sensitivity to Omicron

Avacta shares drop as Covid tests show reduced sensitivity to Omicron

Read more
22 Dec 2021 12:21

LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures

LONDON MARKET MIDDAY: Stocks edge higher ahead of US growth figures

Read more
22 Dec 2021 11:28

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

AIM WINNERS & LOSERS: BlueRock hit by Covid; D4T4 up on contract wins

Read more
22 Dec 2021 10:31

Avacta shares up as flow tests receive CE mark for self-test use

Avacta shares up as flow tests receive CE mark for self-test use

Read more
15 Dec 2021 11:56

Avacta confirms lateral flow tests can detect Omicron variant

Avacta confirms lateral flow tests can detect Omicron variant

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.